EZZ Life Science Holdings
EZZ Life Science Holdings Limited is a genomic life science company focused on enhancing human health through innovative products and cutting-edge genomic research. The company leverages a dynamic omnichannel strategy to distribute premium health and wellness products across Australia, New Zealand, China, and other global markets. EZZ is committed to empowering consumers with science-backed solutions for better health and longevity.
Short position
EZZ Life Science Holdings (ASX:EZZ) has 0.00% of its shares on issue reported as short positions as of 15 Sept 2026, or about 188 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.15% in October 2024. EZZ is classified in the Consumer Discretionary Distribution & Retail industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4EZZ Life Science Holdings (EZZ) financials
Results, ratios and statements
Latest result
Year to 30 Jun 2026 (FY26) vs FY25, figures in AUD, the reporting currency
- Revenue
- $46.3MM (source: ASX (Markit))vs $66.9M (FY25)
- ASX (Markit), as at 29 Sep 2026
- NPAT
- −$5.3MM (source: ASX (Markit))vs $6.7M (FY25)
- ASX (Markit), as at 29 Sep 2026
- EPS (basic)
- n/avs $0.15 (FY25)
- Rev YoY
- −30.8%FY
- EPS YoY
- −9.9%FY
- ASX (Markit)
Summary of Annual Report to shareholders, 1 Sep 2026
EZZ Life Science reported a tough FY26 with revenue falling 36.39% to $46.28 million and a statutory net loss of $5.32 million, compared to a profit in the prior year. No dividend was declared for the year. The company is focused on rebuilding momentum in China, expanding its Australia and New Zealand pharmacy presence, and developing international partnerships, while managing costs carefully in challenging market conditions.
Automated summary of the filing; the filing itself is the record.
Key ratios
Year to 30 Jun 2026 (FY); no balance sheet aligned with this period; prices to 9 Oct 2026
- Gross margin
- n/a
- Operating margin
- n/a
- Net margin
- −11.5%
- FCF margin
- n/a
- ROE
- n/a
- ROA
- n/a
- FCF conversion
- n/a
- Net debt (excl. leases)
- n/a
- Net debt / EBITDA
- n/a
- Current ratio
- n/a
- Interest cover
- n/a
- Cash dividends paid / net profit
- n/a
- Market cap
- n/a (no share count we can vouch for)
- P/E
- 5.9×
- P/B
- n/a (no share count we can vouch for)
Ratios use the reporting currency (AUD); market cap is in AUD. Source: ASX (Markit), as at 29 Sep 2026.
Financial statements
Figures in AUD, the reporting currency; Yahoo Finance unless marked
| Line item | FY26 | FY25 | FY24 | FY23 |
|---|---|---|---|---|
| Revenue | $46.3MM (source: ASX (Markit)) | $66.9M | $66.4M | $37.1M |
| Gross profit | n/a | $49.7M | $50.9M | $28.5M |
| Operating income | n/a | $9.9M | $9.7M | $4.6M |
| EBITDA | n/a | $11.1M | $10.4M | $5.1M |
| EBIT | n/a | $10.6M | $10.0M | $4.9M |
| Interest expense | n/a | $5.5K | $24.8K | $10.4K |
| Pretax income | n/a | $10.6M | $10.0M | $4.9M |
| Tax | n/a | $3.9M | $3.0M | $1.3M |
| NPAT | −$5.3MM (source: ASX (Markit)) | $6.7M | $7.0M | $3.6M |
| Net interest income | n/a | $390.0K | $171.0K | $26.0K |
| EPS basic | n/a | $0.15 | $0.16 | $0.085 |
| EPS diluted | n/a | $0.15 | $0.16 | $0.085 |
| Shares | n/a | 47.2M | 44.4M | 42.7M |
- ASX (Markit)
Financial reports
The company's own filings, newest first
- Annual Report to shareholdersAnnual Report1 Sep 2026via asx_announcements
- Preliminary Final ReportAnnual Results31 Aug 2026via asx_announcements
- Half Yearly Report and AccountsHalf Year Results27 Feb 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cashflow ReportQuarterly Report30 Jan 2026via asx_announcements
- Appendix 4C Quarterly Activity ReportFinancial Report31 Dec 2025via crawler
- Annual Report 2023Annual Report31 Dec 2025via crawler
- Annual Report 2024Annual Report31 Dec 2025via crawler
- Annual Report 2025Annual Report31 Dec 2025via crawler
- Audited Financial StatementFinancial Report31 Dec 2025via crawler
- Annual Report 2022Annual Report31 Dec 2025via crawler
Showing 10 of 70 reports